Latest filing published 18 Jul 2019 for ARATANA THERAPEUTICS, INC..
No signal scores available.
Rhonda Lynette Hellums discloses dealings in Aratana Therapeutics, Inc. to SEC (Form 4). Between 1 February 2019 and 18 July 2019, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 18 July 2019, the filings show a transaction in Aratana Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations